A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage damaged p53. This essential cancer protector protein is frequently lost in several types of malignancies, causing https://bookmarksurl.com/story7635762/vhh-fragments-revive-the-p53-protein-new-potential-approach-for-tumor-management